CUSIP: 58507N105
Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
20,365,727
-
Share change
-
+5,962,001
-
Total reported value
-
$202,208,900
-
Price per share
-
$9.93
-
Number of holders
-
65
-
Value change
-
+$59,608,719
-
Number of buys
-
34
-
Number of sells
-
17
Quarterly Holders Quick Answers
What is CUSIP 58507N105?
CUSIP 58507N105 identifies MTAC - TRISALUS LIFE SCIENCES INC COM - Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2021
-
Previous quarter:
Q2 2021
Recent filing periods for CUSIP 58507N105:
Institutional Holders of TRISALUS LIFE SCIENCES INC COM - Stock (MTAC) as of Q3 2021
As of 30 Sep 2021,
TRISALUS LIFE SCIENCES INC COM - Stock (MTAC) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,365,727 shares.
The largest 10 holders included
BlackRock Inc., Magnetar Financial LLC, Hartree Partners, LP, ARISTEIA CAPITAL LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), MARSHALL WACE, LLP, Linden Advisors LP, GILDER GAGNON HOWE & CO LLC, GLAZER CAPITAL, LLC, and HSBC HOLDINGS PLC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.